For example, in breast cancer (BC) patients, HMGB1 expression serves as an effective indicator of the immunogenicity and efficacy of chemotherapeutic agents, and elevated levels of HMGB1 have been associated with improved clinical outcomes in patients receiving neoadjuvant chemotherapy [305]. The gene discussed is HMGB1; the disease is breast carcinoma.